NHIS-NSC	National Health Insurance Service–National Sample Cohort (Korea)
ASCVD	Atherosclerotic Cardiovascular Disease
ELITE	Early Versus Late Intervention Trial With Estradiol
EMAS	European Menopause and Andropause Society
KEEPS	Kronos Early Estrogen Prevention Study
E4Relief	E4Relief Phase II Trial
CTX-1	C-terminal Telopeptide Of Type I Collagen
NAMS	North American Menopause Society
NK3R	Neurokinin-3 Receptor
DHEA	Dehydroepiandrosterone
SHBG	Sex Hormone-Binding Globulin
HDL-c	High-Density Lipoprotein Cholesterol
LDL-c	Low-Density Lipoprotein Cholesterol
SNRI	Serotonin–Norepinephrine Reuptake Inhibitor
SSRI	Selective Serotonin Reuptake Inhibitor
ART	Assisted Reproductive Technology
BMS	British Menopause Society
CEEs	Conjugated Equine Estrogens
CHD	Coronary Heart Disease
CRC	Colorectal Cancer
CVD	Cardiovascular Disease
EPT	Estrogen–Progestogen Therapy
ERα	Estrogen Receptor Alpha
ERβ	Estrogen Receptor Beta
FMD	Flow-Mediated Dilation
GSM	Genitourinary Syndrome of Menopause
MHT	Menopausal Hormone Therapy
MPA	Medroxyprogesterone Acetate
NMD	Nitroglycerin-Mediated Dilation
TBG	Thyroxine-Binding Globulin
UTIs	Urinary Tract Infections
VMSs	Vasomotor Symptoms
VTE	Venous Thromboembolism
WHI	Women’s Health Initiative
LT4	Levothyroxine
E2	17β-Estradiol
E4	Estetrol
ET	Estrogen Therapy
PR	Progesterone Receptor